Successful treatment of multicentric Castleman's disease with bilateral orbital tumour using rituximab

被引：28

作者：

Ide, M ^{[1
]}

Ogawa, E

Kasagi, K

Kawachi, Y

Ogino, T

机构：

[1] Takamatsu Red Cross Hosp, Dept Internal Med, Kagawa, Japan

[2] Takamatsu Red Cross Hosp, Dept Pathol, Kagawa, Japan

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2003年 / 121卷 / 05期

关键词：

rituximab; multicentric Castleman's disease;

D O I：

10.1046/j.1365-2141.2003.04358.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：818 / 819

页数：3

共 3 条

[1] Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy [J].

Corbellino, M ;

Bestetti, G ;

Scalamogna, C ;

Calattini, S ;

Galazzi, M ;

Meroni, L ;

Manganaro, D ;

Fasan, M ;

Moroni, M ;

Galli, M ;

Parravicini, C .

BLOOD, 2001, 98 (12) :3473-3475

[2] The clinical behavior of localized and multicentric Castleman disease [J].

Herrada, J ;

Cabanillas, F ;

Rice, L ;

Manning, J ;

Pugh, W .

ANNALS OF INTERNAL MEDICINE, 1998, 128 (08) :657-662

[3] Improvement In Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy [J].

Nishimoto, N ;

Sasai, M ;

Shima, Y ;

Nakagawa, M ;

Matsumoto, T ;

Shirai, T ;

Kishimoto, T ;

Yoshizaki, K .

BLOOD, 2000, 95 (01) :56-61

← 1 →